Profile data is unavailable for this security.
About the company
American Well Corporation is an enterprise platform and software company digitally enabling hybrid care. The Company offers a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. It provides its clients with the core technology and services necessary to develop and distribute digital care programs. Its enterprise platform and software as a service solution enable hybrid care delivery by offering its clients products to help weave digital care across all care settings. For health systems, its enterprise platform enables provider-to-provider virtual care for use cases ranging from stroke and acute psychiatry evaluations to virtual nursing and e-sitting. Its suite of Carepoint devices can enhance in-person care, whether the clients want to turn existing equipment such as televisions or iPads into digital access points or use Amwell Carepoint carts and peripherals.
- Revenue in USD (TTM)254.04m
- Net income in USD-214.08m
- Incorporated2006
- Employees1.10k
- LocationAmerican Well Corp75 STATE STREET, 26TH FLOORBOSTON 02109United StatesUSA
- Phone+1 (617) 205-3500
- Fax+1 (302) 636-5454
- Websitehttps://business.amwell.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CRYO-CELL International, Inc. | 31.84m | -8.93m | 63.45m | 82.00 | -- | -- | -- | 1.99 | -1.08 | -1.08 | 3.86 | -1.19 | 0.4798 | 9.35 | 4.78 | 388,274.30 | -13.45 | 0.4686 | -18.45 | 0.7099 | 73.66 | 70.09 | -28.04 | 0.8133 | 0.5699 | -- | -- | -- | 3.32 | 1.41 | -443.57 | -- | 60.30 | -- |
| Exagen Inc | 55.75m | -16.93m | 73.02m | 174.00 | -- | 5.72 | -- | 1.31 | -0.9383 | -0.9383 | 3.09 | 0.7345 | 1.07 | -- | 4.22 | 320,408.00 | -32.39 | -30.21 | -39.53 | -33.75 | 58.80 | 54.86 | -30.36 | -55.36 | -- | -6.88 | 0.6148 | -- | 15.33 | 10.13 | 50.01 | -- | 33.00 | -- |
| 23andMe Holding Co. | 193.26m | -615.31m | 75.91m | 560.00 | -- | 0.7984 | -- | 0.3928 | -25.27 | -25.27 | 7.84 | 3.95 | 0.3451 | 6.93 | 198.52 | 345,107.20 | -109.86 | -- | -142.15 | -- | 46.51 | 46.35 | -318.39 | -121.63 | 1.14 | -- | 0.00 | -- | -26.66 | -13.01 | -113.92 | -- | -19.09 | -- |
| Cardiff Lexington Corp | 7.22m | -2.84m | 97.74m | 10.00 | 0.7895 | -- | -- | 13.54 | 8.23 | 3.61 | 0.9605 | 0.5838 | 0.3436 | -- | 0.542 | 722,096.00 | -9.27 | -- | -25.14 | -- | 49.32 | 62.01 | -26.98 | -- | -- | -0.0099 | 0.4916 | -- | -- | 39.71 | -- | -- | -- | -- |
| American Well Corp | 254.04m | -214.08m | 120.11m | 1.10k | -- | 0.356 | -- | 0.4728 | -14.54 | -14.54 | 17.22 | 22.02 | 0.4545 | 26.31 | 3.74 | 230,104.20 | -38.46 | -28.25 | -49.63 | -32.66 | 34.80 | 40.51 | -84.63 | -121.27 | 2.88 | -- | 0.00 | -- | -6.55 | 17.85 | -149.66 | -- | 51.49 | -- |
| Zomedica Corp | 26.73m | -62.19m | 128.57m | 144.00 | -- | 0.6338 | -- | 4.81 | -0.0635 | -0.0635 | 0.0273 | 0.207 | 0.1093 | 1.77 | 14.31 | 185,604.20 | -25.43 | -14.03 | -26.22 | -14.45 | 69.64 | -- | -232.70 | -220.98 | 10.15 | -- | 0.00 | -- | 33.05 | -- | -102.93 | -- | 89.85 | -- |
| Longduoduo Co Ltd | 7.39m | 1.26m | 153.63m | 49.00 | 122.37 | 218.68 | 104.84 | 20.79 | 0.0418 | 0.0418 | 0.2463 | 0.0234 | 4.17 | 422.80 | 61.99 | 150,812.90 | 76.89 | -- | 1,467.79 | -- | 97.65 | -- | 18.45 | -- | 1.31 | -- | 0.00 | -- | 93.52 | -- | 3,311.69 | -- | -- | -- |
| Nutex Health Inc | 292.00m | -41.13m | 164.90m | 800.00 | -- | 2.62 | -- | 0.5647 | -8.93 | -8.93 | 60.20 | 11.59 | 0.6361 | 90.72 | 4.82 | 365,000.50 | -7.06 | -69.35 | -8.65 | -84.85 | 23.24 | 10.97 | -11.10 | -102.85 | 1.74 | 1.44 | 0.7824 | -- | 12.93 | 428.22 | 89.22 | -- | -- | -- |
| Joint Corp | 120.80m | -16.86m | 170.21m | 444.00 | -- | 8.30 | -- | 1.41 | -1.14 | -1.14 | 8.10 | 1.37 | 1.36 | -- | 30.39 | 272,062.20 | -18.92 | 4.32 | -30.06 | 6.05 | 90.70 | 90.28 | -13.95 | 3.68 | -- | 1,593.99 | 0.0022 | -- | 16.24 | 26.27 | -1,656.09 | -- | 35.09 | -- |
| Biodesix Inc | 65.56m | -43.82m | 173.11m | 217.00 | -- | 6.21 | -- | 2.64 | -0.3941 | -0.3941 | 0.5663 | 0.1915 | 0.6918 | -- | 9.49 | 302,129.00 | -46.24 | -55.60 | -60.89 | -80.94 | 77.72 | 59.53 | -66.84 | -105.15 | -- | -3.91 | 0.5647 | -- | 28.46 | 19.16 | 20.32 | -- | 106.31 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Senvest Management LLCas of 30 Sep 2024 | 1.25m | 9.38% |
| Morgan Stanley & Co. LLCas of 30 Sep 2024 | 1.17m | 8.78% |
| Caledonia (Private) Investments Pty Ltd.as of 30 Sep 2024 | 841.34k | 6.31% |
| The Vanguard Group, Inc.as of 30 Sep 2024 | 615.84k | 4.62% |
| Kent Lake Pr LLCas of 30 Sep 2024 | 256.64k | 1.92% |
| BlackRock Fund Advisorsas of 30 Sep 2024 | 231.07k | 1.73% |
| Renaissance Technologies LLCas of 30 Sep 2024 | 219.86k | 1.65% |
| Millennium Management LLCas of 30 Sep 2024 | 201.87k | 1.51% |
| Rock Point Advisors LLCas of 30 Sep 2024 | 188.09k | 1.41% |
| Apo Asset Management GmbHas of 30 Apr 2024 | 178.89k | 1.34% |
